Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Dummer

Showing results (461-470 of 744) with videos related to

Pageof 75
Sort By:
NPJ Precision Oncology|December 16, 2025
Comparative cost analysis of a diagnostic multi-omics platform for decision support in advanced cancer - results from the Tumor Profiler Melanoma projectTarun Mehra, Dominik Menges, Benedict Gosztonyi, et al.
The Journal of Clinical Investigation|September 5, 2009
A positive FGFR3/FOXN1 feedback loop underlies benign skin keratosis versus squamous cell carcinoma formation in humansAnna Mandinova, Vihren Kolev, Victor Neel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2005
Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology GroupRoland Kaufmann, Konstanze Spieth, Ulrike Leiter, et al.
Skin Health and Disease|December 3, 2024
Gender differences in melanoma awareness, diagnosis and treatment: Patient-reported data from a multicentre survey in SwitzerlandJohanna Mangana, Cristina Lamos, Berna C Özdemir, et al.
European Journal of Immunology|July 19, 2012
Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8⁺ T-cell responses in melanoma patientsSimone M Goldinger, Reinhard Dummer, Petra Baumgaertner, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 26, 2008
Short German guidelines: malignant melanomaClaus Garbe, Dirk Schadendorf, Wilhelm Stolz, et al.
The Journal of Clinical Investigation|November 6, 2018
Androgen receptor functions as transcriptional repressor of cancer-associated fibroblast activationAndrea Clocchiatti, Soumitra Ghosh, Maria-Giuseppina Procopio, et al.
Melanoma Research|January 30, 2008
Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanomaClaus Garbe, Axel Hauschild, Matthias Volkenandt, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 14, 2023
The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas: A retrospective cohort study from five European skin cancer reference centresAlexander Troesch, Magdalena Hoellwerth, Stephan Forchhammer, et al.
Cell Death & Disease|December 21, 2024
TGFβ signaling sensitizes MEKi-resistant human melanoma to targeted therapy-induced apoptosisBenjamin Loos, Adrian Salas-Bastos, Anna Nordin, et al.
Pageof 75

Showing results (461-470 of 744) with videos related to

Sort By:
Pageof 75
NPJ Precision Oncology|December 16, 2025
Comparative cost analysis of a diagnostic multi-omics platform for decision support in advanced cancer - results from the Tumor Profiler Melanoma projectTarun Mehra, Dominik Menges, Benedict Gosztonyi, et al.
The Journal of Clinical Investigation|September 5, 2009
A positive FGFR3/FOXN1 feedback loop underlies benign skin keratosis versus squamous cell carcinoma formation in humansAnna Mandinova, Vihren Kolev, Victor Neel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2005
Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology GroupRoland Kaufmann, Konstanze Spieth, Ulrike Leiter, et al.
Skin Health and Disease|December 3, 2024
Gender differences in melanoma awareness, diagnosis and treatment: Patient-reported data from a multicentre survey in SwitzerlandJohanna Mangana, Cristina Lamos, Berna C Özdemir, et al.
European Journal of Immunology|July 19, 2012
Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8⁺ T-cell responses in melanoma patientsSimone M Goldinger, Reinhard Dummer, Petra Baumgaertner, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 26, 2008
Short German guidelines: malignant melanomaClaus Garbe, Dirk Schadendorf, Wilhelm Stolz, et al.
The Journal of Clinical Investigation|November 6, 2018
Androgen receptor functions as transcriptional repressor of cancer-associated fibroblast activationAndrea Clocchiatti, Soumitra Ghosh, Maria-Giuseppina Procopio, et al.
Melanoma Research|January 30, 2008
Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanomaClaus Garbe, Axel Hauschild, Matthias Volkenandt, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 14, 2023
The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas: A retrospective cohort study from five European skin cancer reference centresAlexander Troesch, Magdalena Hoellwerth, Stephan Forchhammer, et al.
Cell Death & Disease|December 21, 2024
TGFβ signaling sensitizes MEKi-resistant human melanoma to targeted therapy-induced apoptosisBenjamin Loos, Adrian Salas-Bastos, Anna Nordin, et al.
Pageof 75